US$ 23.66
pioneer 9 semaglutide Dose-response, efficacy, and safety of oral monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial Cardiovascular Outcomes, Safety, and Tolerability
Description
97% purity, lyophilized

Access this presentation on ESC 365 from ESC Congress 2025 on Cardiovascular Pharmacotherapy by Ms L
Weight loss medications and peptides like Ozempic (semaglutide) and retatrutide are everywhere right now and so are questions about how they affect hormones, cycles, and periods.

Gastric-emptying pathways and nutrient-response signaling research

PlexusDx explains why monotherapy is standard and how genetic testing helps identify your ideal single-agent approach
